FIELD: thiazolactam compounds.
SUBSTANCE: invention is related to thiazolactam compounds of formula (III), where the values of R1-R5, n, m are defined in the claims.
EFFECT: used in preparation of drugs for treatment of diseases associated with ERK.
16 cl, 2 dwg, 6 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SPIRO COMPOUNDS AS ERK INHIBITORS AND THEIR USE | 2020 |
|
RU2800042C1 |
| BICYCLIC COMPOUND AS RIP-1 KINASE INHIBITOR AND ITS USE | 2020 |
|
RU2800652C2 |
| PDE4 INHIBITOR | 2017 |
|
RU2743126C2 |
| TRICYCLIC COMPOUNDS AFFECTING CRBN PROTEINS | 2019 |
|
RU2801068C2 |
| THIOPHENE COMPOUND, ITS PRODUCTION METHOD AND ITS PHARMACEUTICAL APPLICATION | 2017 |
|
RU2709473C1 |
| FGFR INHIBITOR AND ITS MEDICAL USE | 2018 |
|
RU2771311C2 |
| PYRIDOPYRIMIDINE COMPOUNDS ACTING AS DOUBLE INHIBITORS OF mTORC 1/2 | 2018 |
|
RU2771201C2 |
| ALPHA-AMINOAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREWITH | 2015 |
|
RU2673622C2 |
| 2,3-DIHYDRO-1H-PYRROLISINE-7-FORMAMIDE DERIVATIVE AND ITS APPLICATIONS | 2019 |
|
RU2792726C2 |
| PYRIMIDINE DERIVATIVES AGAINST INFLUENZA VIRUS | 2017 |
|
RU2727772C1 |
